Cost-Effectiveness of Treating Esophageal Varices

Jayant A. Talwalkar

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations

Abstract

Based on gaps in knowledge regarding the outcomes of existing strategies for primary and secondary prophylaxis of esophageal varices, several cost-effectiveness analyses have been performed to determine the relative value of these approaches. Conflicts between universal and targeted beta-blocker therapy remain unresolved for primary prophylaxis. The usefulness of HDM for primary prophylaxis is equally unknown. In terms of secondary prophylaxis, the use of combination medical therapy appears cost-effective (especially with HDM). Unfortunately, a great deal of uncertainty remains about the precision of any ICER in the absence of data regarding patient preference and compliance with prescribed strategies. However, the conduct of these studies has served the purpose for highlighting areas of need in terms of further study. Subsequent knowledge, therefore, should be incorporated in revised analyses over time to improve our ability as clinicians to provide maximal health benefits in the setting of appropriate resource use.

Original languageEnglish (US)
Pages (from-to)679-689
Number of pages11
JournalClinics in liver disease
Volume10
Issue number3
DOIs
StatePublished - Aug 2006

ASJC Scopus subject areas

  • Hepatology

Fingerprint Dive into the research topics of 'Cost-Effectiveness of Treating Esophageal Varices'. Together they form a unique fingerprint.

Cite this